LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 92

Suchoptionen

  1. Artikel ; Online: Are There Thresholds of Conflict of Interest With Gifts From Industry? Comment on the Article by Wayant et al.

    FitzGerald, John D

    Arthritis & rheumatology (Hoboken, N.J.)

    2021  Band 73, Heft 9, Seite(n) 1770

    Mesh-Begriff(e) Conflict of Interest ; Drug Industry ; Gift Giving ; Humans ; Physicians
    Sprache Englisch
    Erscheinungsdatum 2021-07-21
    Erscheinungsland United States
    Dokumenttyp Letter ; Comment
    ZDB-ID 2756371-6
    ISSN 2326-5205 ; 2326-5191
    ISSN (online) 2326-5205
    ISSN 2326-5191
    DOI 10.1002/art.41721
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Changes in the Workforce Characteristics of Providers Who Care for Adult Patients With Rheumatologic and Musculoskeletal Disease in the United States.

    Mannion, Melissa L / Xie, Fenglong / FitzGerald, John D / Alexander, Amanda / Mudano, Amy / Su, Yujie / Saag, Kenneth G / Curtis, Jeffrey R

    Arthritis & rheumatology (Hoboken, N.J.)

    2024  

    Abstract: Objective: The aim of this study was to describe the adult rheumatology workforce in the United States, assess change in rheumatology providers over time, and identify variation in rheumatology practice characteristics.: Methods: Using national ... ...

    Abstract Objective: The aim of this study was to describe the adult rheumatology workforce in the United States, assess change in rheumatology providers over time, and identify variation in rheumatology practice characteristics.
    Methods: Using national Medicare claims data from 2006 to 2020, clinically active rheumatology physicians and advanced practice providers (APPs) were identified. Each calendar year was used for inclusion, exclusion, and analysis, and providers were determined to be entering, exiting, or stable based upon presence or absence in the prior or subsequent years of data. Characteristics (age, gender, practice type, rural, and region) of rheumatologists were determined for 2019 and in mutually exclusive study periods from 2009 to 2011, 2012 to 2015, and 2016 to 2019. The location of rheumatology practice was determined by billing tax identification and mapped. Demographics of physicians exiting or entering the rheumatology workforce were compared separately to those stable by logistic regression.
    Results: The clinically active adult rheumatology workforce identified in US Medicare in 2019 was 5,667 rheumatologists and 379 APPs. From 2009 to 2020, the number of rheumatologists increased 23% and the number of APPs increased 141%. There was an increase in female rheumatologists over time, rising to 43% in 2019. Women and those employed by a health care system were more likely to exit, and those in a small practice or in the South were less likely to exit.
    Conclusion: The overall number of clinically active rheumatology providers grew more than 20% over the last decade to a high of 6,036 in 2020, although this rate of growth appears to be flattening off in later years.
    Sprache Englisch
    Erscheinungsdatum 2024-02-25
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2756371-6
    ISSN 2326-5205 ; 2326-5191
    ISSN (online) 2326-5205
    ISSN 2326-5191
    DOI 10.1002/art.42833
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Patient Perspectives on Gout and Gout Treatments: A Patient Panel Discussion That Informed the 2020 American College of Rheumatology Treatment Guideline.

    Singh, Jasvinder A / Neogi, Tuhina / FitzGerald, John D

    ACR open rheumatology

    2020  Band 2, Heft 12, Seite(n) 725–733

    Abstract: Objective: The objective of this study was to understand patient perspectives to inform the voting process for the 2020 American College of Rheumatology (ACR) gout treatment guideline.: Methods: We conducted a panel meeting of eight patients with ... ...

    Abstract Objective: The objective of this study was to understand patient perspectives to inform the voting process for the 2020 American College of Rheumatology (ACR) gout treatment guideline.
    Methods: We conducted a panel meeting of eight patients with gout in Birmingham, Alabama. Patients were referred to the project by private and academic rheumatologists in the Birmingham area. All participants received orientation related to the guideline development process and evidence rating at the beginning of the meeting. With the help of a physician moderator, the patient panel reviewed nine key clinical scenarios and the supporting evidence and discussed their views and perspectives related to each. They also provided their preference for one of the two treatment options for each clinical scenario.
    Results: The patient panel included eight men with gout. Of these eight participants, seven received their gout care from a rheumatologist and one from a primary care physician. Patients favored more active urate-lowering therapy (ULT) management and interventional management of gout flares to achieve desired clinical outcomes, resulting in unanimous consensus on choices related to six clinical scenarios: ULT initiation in gout, treat-to-target management strategy, use of pegloticase for refractory gout, starting ULT during a gout flare, using injectable treatments (over oral) for acute gout flares, and use of febuxostat in people with cardiovascular disease.
    Conclusion: Knowledge of patient preferences and values is valuable and was influential for the development of the 2020 ACR gout treatment guideline.
    Sprache Englisch
    Erscheinungsdatum 2020-11-22
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ISSN 2578-5745
    ISSN (online) 2578-5745
    DOI 10.1002/acr2.11199
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Good Intentions, Unintended Consequences, and Unrealized Benefits.

    FitzGerald, John D

    Journal of general internal medicine

    2015  Band 30, Heft 11, Seite(n) 1581–1583

    Mesh-Begriff(e) Colchicine/therapeutic use ; Drug Utilization/trends ; Female ; Gout/drug therapy ; Gout Suppressants/therapeutic use ; Humans ; Male
    Chemische Substanzen Gout Suppressants ; Colchicine (SML2Y3J35T)
    Sprache Englisch
    Erscheinungsdatum 2015-11
    Erscheinungsland United States
    Dokumenttyp Comment ; Editorial
    ZDB-ID 639008-0
    ISSN 1525-1497 ; 0884-8734
    ISSN (online) 1525-1497
    ISSN 0884-8734
    DOI 10.1007/s11606-015-3458-4
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: A hundred and fifty years of vital statistics

    FitzGerald, John D

    Journal of the Statistical and Social Inquiry Society of Ireland Bd. XLV.2015/16, S. 177-201

    documenting demographic change in Ireland

    2016  

    Verfasserangabe John Fitzgerald
    Schlagwörter Bevölkerungsstatistik ; Bevölkerungsentwicklung ; Irland
    Sprache Englisch
    Umfang Online-Ressource
    Erscheinungsort Dublin
    Dokumenttyp Artikel ; Online
    ZDB-ID 2217621-4
    Datenquelle ECONomics Information System

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Reply.

    Neogi, Tuhina / Dalbeth, Nicola / Mikuls, Ted R / Turner, Amy S / FitzGerald, John D

    Arthritis & rheumatology (Hoboken, N.J.)

    2021  Band 73, Heft 3, Seite(n) 544–545

    Mesh-Begriff(e) Gout ; Humans ; Rheumatology ; United States
    Sprache Englisch
    Erscheinungsdatum 2021-01-27
    Erscheinungsland United States
    Dokumenttyp Letter ; Research Support, N.I.H., Extramural ; Comment
    ZDB-ID 2756371-6
    ISSN 2326-5205 ; 2326-5191
    ISSN (online) 2326-5205
    ISSN 2326-5191
    DOI 10.1002/art.41522
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Buch ; Online: Managing a century of debt

    FitzGerald, John D / Kenny, Sean

    (Lund papers in economic history ; no. 171)

    2018  

    Verfasserangabe John FitzGerald & Seán Kenny
    Serientitel Lund papers in economic history ; no. 171
    Schlagwörter Öffentliche Schulden ; Schuldenmanagement ; Kapitalkosten ; Irland
    Sprache Englisch
    Umfang 1 Online-Ressource (circa 43 Seiten)
    Dokumenttyp Buch ; Online
    Datenquelle ECONomics Information System

    Zusatzmaterialien

    Kategorien

  8. Buch ; Online: 'Till debt do us part'

    FitzGerald, John D / Kenny, Sean

    financial implications of the divorce of the Irish Free State from the UK, 1922-6

    (Lund papers in economic history ; no. 166)

    2017  

    Verfasserangabe John FitzGerald and Seán Kenny
    Serientitel Lund papers in economic history ; no. 166
    Schlagwörter Öffentliche Schulden ; Internationale Staatsschulden ; Verhandlungen ; Irland ; Großbritannien
    Sprache Englisch
    Umfang 1 Online-Ressource (circa 38 Seiten), Illustrationen
    Dokumenttyp Buch ; Online
    Datenquelle ECONomics Information System

    Zusatzmaterialien

    Kategorien

  9. Artikel: Treatment approaches and adherence to urate-lowering therapy for patients with gout.

    Aung, Thanda / Myung, Gihyun / FitzGerald, John D

    Patient preference and adherence

    2017  Band 11, Seite(n) 795–800

    Abstract: Gout is the most common inflammatory arthritis characterized by painful disabling acute attacks. It is caused by hyperuricemia and deposition of urate crystals in and around the joints. Long-standing untreated hyperuricemia can lead to chronic arthritis ... ...

    Abstract Gout is the most common inflammatory arthritis characterized by painful disabling acute attacks. It is caused by hyperuricemia and deposition of urate crystals in and around the joints. Long-standing untreated hyperuricemia can lead to chronic arthritis with joint damage, tophi formation and urate nephropathy. Gout is associated with significant morbidity and health care associated cost. The goal of long-term therapy is to lower the serum urate level to promote dissolution of urate crystals, reduce recurrent acute gout flares, resolve tophi and prevent joint damage. Despite the presence of established gout treatment guidelines and effective medications to manage gout, patient outcomes are often poor. Etiology for these shortcomings is multifactorial including both physician and patient characteristics. Poor adherence to urate-lowering therapy (ULT) is prevalent and is a significant contributor to poor patient outcomes. This article reviews the treatment strategies for the management of hyperuricemia in chronic gout, gaps in quality of care in gout management, factors contributing to poor adherence to ULT and discusses potential interventions to achieve improved gout-related outcomes. These interventions include initiation of prophylactic anti-inflammatory medication when starting ULT, frequent follow-ups, regular serum urate monitoring and improved patient education, which can be achieved through pharmacist- or nurse-assisted programs. Interventions such as these could improve adherence to ULT and, ultimately, result in optimal gout-related outcomes.
    Sprache Englisch
    Erscheinungsdatum 2017-04-19
    Erscheinungsland New Zealand
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2455848-5
    ISSN 1177-889X
    ISSN 1177-889X
    DOI 10.2147/PPA.S97927
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin.

    Bae, Sangmee Sharon / Faure-Kumar, Emmanuelle / Ferbas, Kathie / Wang, Jennifer / Shahbazian, Ani / Truong, Linh / Yang, Howard / McMahon, Maureen / FitzGerald, John D / Charles-Schoeman, Christina

    Rheumatology international

    2023  Band 43, Heft 9, Seite(n) 1629–1636

    Abstract: Antibodies to Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) have been reported in pooled healthy donor plasma and intravenous immunoglobulin products (IVIG). It is not known whether administration of IVIG increases circulating anti-SARS- ... ...

    Abstract Antibodies to Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) have been reported in pooled healthy donor plasma and intravenous immunoglobulin products (IVIG). It is not known whether administration of IVIG increases circulating anti-SARS-CoV-2 antibodies (COVID ab) in IVIG recipients. COVID ab against the receptor binding domain of the spike protein were analyzed using a chemiluminescent microparticle immunoassay in patients with idiopathic inflammatory myopathies (IIM) both receiving and not receiving IVIG (IVIG and non-IVIG group, respectively). No significant differences in COVID ab levels were noted between IVIG and non-IVIG groups (417 [67-1342] AU/mL in IVIG vs 5086 [43-40,442] AU/mL in non-IVIG, p = 0.11). In linear regression models including all post-vaccination patient samples, higher number of vaccine doses was strongly associated with higher COVID ab levels (2.85 [1.21, 4.48] log AU/mL, regression coefficient [Formula: see text] [95% CI], p = 0.001), while use of RTX was associated with lower ab levels (2.73 [- 4.53, - 0.93] log AU/mL, [Formula: see text][95%CI], p = 0.004). In the IVIG group, higher total monthly doses of IVIG were associated with slightly higher COVID ab levels (0.02 [0.002-0.05] log AU/mL, p = 0.04). While patients on IVIG did not have higher COVID ab levels compared to the non-IVIG group, higher monthly doses of IVIG were associated with higher circulating levels of COVID ab in patients receiving IVIG, particularly in patients concomitantly receiving RTX. Our findings suggest that IIM patients, especially those at increased risk of COVID infection and worse COVID outcomes due to RTX therapy may have protective benefits when on concurrent IVIG treatment.
    Mesh-Begriff(e) Humans ; Immunoglobulins, Intravenous/therapeutic use ; SARS-CoV-2 ; COVID-19 ; Antibodies, Viral ; Myositis/drug therapy ; Vaccination
    Chemische Substanzen Immunoglobulins, Intravenous ; Antibodies, Viral
    Sprache Englisch
    Erscheinungsdatum 2023-06-27
    Erscheinungsland Germany
    Dokumenttyp Journal Article
    ZDB-ID 8286-7
    ISSN 1437-160X ; 0172-8172
    ISSN (online) 1437-160X
    ISSN 0172-8172
    DOI 10.1007/s00296-023-05350-1
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang